ClinicalTrials.gg
CompletedNCT00086268ZPACTUpdated Sep 13, 2017

Non-small Cell Lung Cancer Study US75 (Z-PACT)

A Phase 3 interventional study of zoledronic acid and Taxotere in Non Small Cell Lung Carcinoma, sponsored by Novartis Pharmaceuticals. Completed at 80 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-09-13.

Sponsored by Novartis Pharmaceuticals (part of Novartis) · Phase 3, Interventional, and Prevention

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
250
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 198 studies testing docetaxel in Carcinoma, Non-Small-Cell Lung — 13 open to participants now, 20 under way, 3 of them phase 3. Docetaxel · Carcinoma, Non-Small-Cell Lung.

Enrollment
28th of 188
250 · median 50
Started
2004
with 20 others
Phase 3
30 of 198
1 open now
Registered
38th of 198
by date

Among the 198 studies testing docetaxel in Carcinoma, Non-Small-Cell Lung, this one is the 28th largest by enrollment of the 188 interventional ones that give a count, is one of 21 that started in 2004, is one of 30 in phase 3, and was the 38th registered.

Carcinoma, Non-Small-Cell Lung

7,635 studies on the registry are indexed under Carcinoma, Non-Small-Cell Lung; 1,840 are open to participants now.

Browse Carcinoma, Non-Small-Cell Lung studies →

Open to participants now

13 of the 198 studies testing docetaxel in Carcinoma, Non-Small-Cell Lung are open now, in 8 countries. Recruiting first, the newest first:

8 more — sign in →

By country, each count listing its studies:

All 13 open studies →

About docetaxel

Docetaxel: first FDA approval 1996 (TAXOTERE), first EMA approval 1995. What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 1,326 Carcinoma, Non-Small-Cell Lung studies recruiting now, 989 (75%) set no upper age limit and 225 (17%) stop at 75 or younger; 34 take children under 18; 40 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 198 studies testing docetaxel in Carcinoma, Non-Small-Cell Lung, or all of them as a file.
02

Study summary

This study will evaluate the effects of an investigational drug in combination with chemotherapy in patients with stage IIIB/IV non-small cell lung cancer. This study will measure the effects of this combination on progression of lung cancer, cancer response to treatments, and development of cancer-related bone lesions.

03

Conditions studied

  • Non Small Cell Lung Carcinoma

Keywords

  • lung cancer
  • ZPACT
  • US75
  • Bone Metastases
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or Female patients at least of 18 years old
  • Patients with diagnosed non-small cell lung cancer that cannot be treated by surgery
  • Women must not be pregnant or attempting to become pregnant
  • Able and willing to sign

Exclusion criteria

Exclusion Criteria:

  • Patients with cancer that has spread to the bone
  • Patients with cancer that has spread to the brain who are receiving treatment
  • Patients with kidney disease
  • Patients treated with other drugs
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

05

Study design

Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
250 participants (actual)

Study arms

  • Experimental
    Zometa®

    4mg monthly for 12 months from date of first chemotherapy dose

    Drug: zoledronic acid · Drug: Taxotere · Drug: Carboplatin

  • No intervention
    no further treatment

    Control arm; no further treatment. Follow-up monthly for 12 months from date of first chemotherapy dose

Interventions

06

Study locations

80 sites
  • Clinical Research Consultants
    Hoover, Alabama 35216, United States
  • Arizona Oncology Assoc.
    Tucson, Arizona 85715, United States
  • NEA Clinic
    Jonesboro, Arkansas 72401, United States
  • Highlands Oncology Group
    Springdale, Arkansas 72764, United States
  • NorthBay Cancer Center
    Fairfield, California 94533, United States
  • UCLA
    Los Angeles, California 91401, United States
  • Clinical Trials and Research Associates, Inc.
    Montebello, California 90640, United States
  • Med. Oncology Care Associates
    Orange, California 92868, United States
  • Cancer Center of Santa Barbara
    Santa Barbara, California 93105, United States
  • Cancer Center of Colorado Springs
    Colorado Springs, Colorado 80907, United States
  • Northern Hematology-Oncology
    Thornton, Colorado 80260, United States
  • Lynn Regional Cancer Center
    Boca Raton, Florida 33428, United States
  • New Hope Cancer Centers
    Hudson, Florida 34667, United States
  • Oceola Cancer Center
    Kissimmee, Florida 34741, United States
  • Innovative Medical Research of South Florida, Inc.
    Miami Shores, Florida 33138, United States
  • VA Medical Center
    Miami, Florida 33125, United States
  • NCH Healthcare System Oncology Research
    Naples, Florida 34102, United States
  • Metcare Oncology
    Ormond Beach, Florida 32174, United States
  • Hematology-Oncology Associates
    Pensacola, Florida 32501, United States
  • AMIT SHAH Medical Group
    Sebring, Florida 33872, United States
  • Peachtree Hematology & Oncology
    Atlanta, Georgia 30309, United States
  • Emory University
    Atlanta, Georgia 30322, United States
  • Straub Clinic & Hospital
    Honolulu, Hawaii 96813, United States
  • Kaiser Foundation Hospital
    Honolulu, Hawaii 96819, United States
  • Advocate Illinois Masonic Medical Center Creticos Cancer Center
    Chicago, Illinois 60657, United States
  • OSF Center for Cancer Care
    Rockford, Illinois 61108, United States
  • Springfield Clinic, LLP
    Springfield, Illinois 62703, United States
  • Central Indiana Cancer Centers
    Indianapolis, Indiana 46219, United States
  • Oncology Institute of Greater Lafayette
    Lafayette, Indiana 47904, United States
  • Community Hospital, Cancer Research Dept.
    Munster, Indiana 46321, United States
  • Northern Indiana Oncology Associates
    South Bend, Indiana 46617, United States
  • Cedar Valley Medical Specialists
    Waterloo, Iowa 50702, United States
  • Kansas City Cancer Ctr. South
    Lenexa, Kansas 66214, United States
  • Hematology/Oncology Clinic
    Baton Rouge, Louisiana 70808, United States
  • Mary Bird Perkins Cancer Center
    Baton Rouge, Louisiana 70809, United States
  • LSU Health Sciences Center
    Shreveport, Louisiana 71103, United States
  • Maine Center for Cancer Medicine
    Scarborough, Maine 04074, United States
  • Oncology Care Associates
    Bethesda, Maryland 20817, United States
  • Berkshire Hematology Oncology PC
    Pittsfield, Massachusetts 01201, United States
  • Karmanos Cancer Institute
    Detroit, Michigan 48201, United States
  • Kalamazoo Hematology & Oncology
    Kalamazoo, Michigan 49048, United States
  • Mitchell Folbe, MD, PC
    Troy, Michigan 48085, United States
  • Park Nicollett Institute
    Saint Louis Park, Minnesota 55416, United States
  • St. Louis Cancer Care
    Chesterfield, Missouri 63017, United States
  • Southeast Nebraska Cancer Center
    Lincoln, Nebraska 68510, United States
  • Odyssey Research
    Scottsbluff, Nebraska 69361, United States
  • Southern Nevada Cancer Research Foundation
    Las Vegas, Nevada 89106, United States
  • Nevada Cancer Center
    Las Vegas, Nevada 89109, United States
  • East Orange VA Medical System
    East Orange, New Jersey 07018, United States
  • Howell Office Plaza
    Howell, New Jersey 07731, United States
  • Atlantic Hem Onc Associates, LLC
    Manasquan, New Jersey 08736, United States
  • Hematology/Oncology Assoc. of South Jersey
    Mount Holly, New Jersey 08060, United States
  • Cancer Institute of New Jersey at Cooper University Hospital
    Voorhees, New Jersey 08043, United States
  • New Mexico Oncology Hematology Consultants, Ltd.
    Albuquerque, New Mexico 87109, United States
  • San Juan Regional Cancer Ctr.
    Farmington, New Mexico 87401, United States
  • New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505, United States
  • Engracio Cortes, MD
    Bayside, New York 11361, United States
  • Arena Oncology Assoc.
    Great Neck, New York 11021, United States
  • James P. Wilmot Cancer Center
    Rochester, New York 16642, United States
  • SUNY Upstate Medical University
    Syracuse, New York 13210, United States
  • Syracuse VA Medical Center
    Syracuse, New York 13210, United States
  • Presbyterian Hospital
    Charlotte, North Carolina 28204, United States
  • Southern Oncology Research
    Grifton, North Carolina 28530, United States
  • Barberton Citizens Hospital-Cancer Center
    Barberton, Ohio 44203, United States
  • Dayton Clinical Oncology Program
    Dayton, Ohio 45429, United States
  • Forum Health Cancer CareCenter
    Youngstown, Ohio 44501, United States
  • Cancer Specialists of Oklahoma
    Oklahoma City, Oklahoma 73112, United States
  • Hematology Oncology Associates
    Medford, Oregon 97504, United States
  • Charleston Hematology Oncology
    Charleston, South Carolina 29403, United States
  • Charleston Cancer Center
    Charleston, South Carolina 29406, United States
  • Liberty Hematology-Oncology
    Columbia, South Carolina 29203, United States
  • Santee Hematology/Oncology
    Sumter, South Carolina 29150, United States
  • The Jones Clinic
    Germantown, Tennessee 38138, United States
  • Knoxville Cancer Center
    Knoxville, Tennessee 27909, United States
  • Cancer Specialists of South Texas
    Corpus Christi, Texas 78412, United States
  • Blood and Cancer Center of East Texas
    Tyler, Texas 75701, United States
  • Tyler Hematology Oncology, PA
    Tyler, Texas 75701, United States
  • Odyssey Research
    Belle Haven, Virginia 23306, United States
  • Masoom Kandahari, MD
    Woodbridge, Virginia 22191, United States
  • West Virginia University
    Morgantown, West Virginia 26506, United States
07

References and documents

Publications

  • Pandya KJ, Gajra A, Warsi GM, Argonza-Aviles E, Ericson SG, Wozniak AJ. Multicenter, randomized, phase 2 study of zoledronic acid in combination with docetaxel and carboplatin in patients with unresectable stage IIIB or stage IV non-small cell lung cancer. Lung Cancer. 2010 Mar;67(3):330-8. doi: 10.1016/j.lungcan.2009.04.020. Epub 2009 Jun 2. PubMed 19493585 ↗
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Apr 2004, a primary completion of Oct 2007 and a completion of Oct 2007. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 29, 2004
First posted
Jul 1, 2004
Start
Apr 2004
Primary completionActual
Oct 2007
CompletionActual
Oct 2007
Last update
Sep 13, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 13, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00086268
Responsible party
Sponsor
First posted
Jul 1, 2004
Start date
Apr 2004
Primary completion
Oct 2007
Completion
Oct 2007
Last update
Sep 13, 2017

Study contacts

Novartis Pharmaceuticals
study director · Novartis Pharmaceuticals
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Zoledronic Acid · Docetaxel · Carboplatin

Start the discussion